Solventum SOLV Cost of product — Cost of Sales
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Solventum in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The official record: Solventum’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Solventum's cost of product — cost of sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Solventum's cost of product — cost of sales?
- Solventum (SOLV) reported cost of product — cost of sales of $796M in Q1 2026.
- How has Solventum's cost of product — cost of sales changed year-over-year?
- Solventum's cost of product — cost of sales decreased by 4.7% year-over-year, from $835M to $796M.
- What is the long-term trend for Solventum's cost of product — cost of sales?
- Over 3 years (2022 to 2025), Solventum's cost of product — cost of sales has grown at a 4.8% compound annual growth rate (CAGR), from $2.95B to $3.4B.
- What does cost of product — cost of sales mean?
- The total direct expenses incurred to manufacture and deliver the products sold by this segment.
- How do you interpret cost of product — cost of sales?
- An increase relative to sales suggests margin compression due to rising input costs or manufacturing inefficiencies, while a decrease relative to sales suggests improved operational leverage.
- How does cost of product — cost of sales compare across companies?
- Comparable to cost of goods sold (COGS) reported by business units in peer healthcare technology and medical device companies.